Hirotaka Konishi

12PUBLICATIONS
33CO-AUTHORS
Medical ethicsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 04, 2026
Tri-Scenario-Based MAICOHAN Strategy for Minimally Invasive Extended Left Hepatectomy.

|Apr 06, 2026
Endoscopic Features of Background Gastritis Associated With Remnant Gastric Cancer: A Multicenter Retrospective Study.

Takuma Ohashi, Takeshi Kubota, Hayato Fukui

|Mar 09, 2026
Minimally Invasive Esophagectomy for Esophageal Cancer: Current Evidence and Future Perspectives.

Hirotaka Konishi, Hiroyuki Inoue, Hitoshi Fujiwara

|Sep 20, 2024
Extracellular glypican-1 affects tumor progression and prognosis in esophageal cancer.

Rie Shibata, Hirotaka Konishi, Tomohiro Arita

|May 16, 2023
Plasma miR-1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer.

Yusuke Takashima, Shuhei Komatsu, Takuma Ohashi

|Dec 19, 2022
Plasma microRNA-192-5p can predict the response to neoadjuvant chemotherapy and prognosis in esophageal cancer.

Hirotaka Furuke, Hirotaka Konishi, Tomohiro Arita

Pageof 2

Frequent Collaborators

10 joint publications

Atsushi Shiozaki

8 joint publications

Shuhei Komatsu

3 joint publications

Hitoshi Fujiwara

3 joint publications

Eigo Otsuji